The Use of Hormonal Growth Factors in the Treatment of Patients with Short-Bowel Syndrome

Author： Jeppesen Palle B.  

Publisher： Adis International

ISSN： 0012-6667

Source： Drugs, Vol.66, Iss.5, 2006-01, pp. : 581-589

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Somatropin for the treatment of short bowel syndrome in adults

By Matarese Laura E   Abu-Elmagd Kareem  

Expert Opinion on Pharmacotherapy, Vol. 6, Iss. 10, 2005-08 ,pp. : 1741-1750

Informa Healthcare

Access to resources Recommend Favorite

Haemopoietic growth factors in the treatment of myelodysplastic syndrome

By Fra MD Gian Paolo   Avanzi MD Gian Carlo  

Expert Opinion on Therapeutic Patents, Vol. 16, Iss. 11, 2006-11 ,pp. : 1557-1568

Informa Healthcare

Access to resources Recommend Favorite

Crofelemer is promising for the treatment for patients with diarrhoea-predominant irritable bowel syndrome

By  

Inpharma, Vol. 1, Iss. 1590, 2007-01 ,pp. : 8-8

Adis International

Access to resources Recommend Favorite

Somatropin (Zorbtive™): In Short Bowel Syndrome

By Keating G.M.   Wellington K.  

Drugs, Vol. 64, Iss. 12, 2004-01 ,pp. : 1375-1381

Adis International

Access to resources Recommend Favorite

The Use of Hematopoietic Growth Factors in the Treatment of Acute Leukemia

By  

Current Pharmaceutical Design, Vol. 8, Iss. 5, 2002-03 ,pp. : 343-355

Bentham Science Publishers

Access to resources Recommend Favorite